解码克隆性血液形成:新兴主题和新的机制见解
Shalmali Pendse1,2,3, Dirk Loeffler1,2,3
1Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Cancers
|August 10, 2024
概括
克隆性血液形成 (CH),突变克隆在血液干细胞中的扩张,在老年人中很常见,并且与疾病风险增加有关. 炎症可能驱动这个过程,影响干细胞的行为并促进疾病.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 克隆性造血 (CH) 涉及突变造血干细胞 (HSC) 的扩张,增加了血液学和非血液学疾病的风险,包括心血管疾病.
- 曾经认为CH只影响少数老年人群,但进展表明它在老年人中普遍存在,并且可以在生命的早期开始.
- 异常炎症越来越被认为是克隆扩张和CH疾病进展的潜在驱动因素.
研究的目的:
- 审查目前对驱动CH的细胞机制的理解.
- 专注于促炎因素在正常和突变的高血压细胞的命运中的作用.
- 阐明促进CH中克隆选择的途径.
主要方法:
- 关于克隆性血液形成的最新科学文献的综述.
- 单细胞测序和生物信息学数据的分析.
- 遗传学重建和敏感测序技术.
主要成果:
- 扩大突变克隆的CH在老年人中普遍存在,并且可能比以前认为的早几十年.
- 环境因素,特别是炎症,似乎在促进CH中发挥着重要作用.
- 支持炎症的因素影响HSC命运,驱动克隆选择.
结论:
- 冠状动脉炎是一种广泛的现象,其起源很早,受到炎症等环境因素的影响.
- 了解炎症和HSC之间的相互作用对于阐明CH机制至关重要.
- 需要进行进一步的研究,以确定CH中克隆扩张的精确驱动因素和途径.
关键词:
第111章 没有了这就是CHIP CHIP.在 Dnmt3a 中使用.Tet2 Tet2 Tet2 Tet2 Tet2 Tet2 Tet2 Tet2 Tet2 Tet2 Tet2克隆的进化过程克隆性血液形成 (clonal hematopoiesis) 是一种细胞形成的过程.克隆性选择 克隆性选择造血干细胞 造血干细胞这是一种炎症炎症炎症炎症.它是自我更新的.更多相关视频
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
12.2K
11:06Combining Intravital Fluorescent Microscopy IVFM with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
7.9K
相关概念视频
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
